Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of 18F-FDG PET/CT in the Early Prediction of Cachexia in Lung Cancer Patients

NCT05912465 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT05912465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05912465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of 18F-FDG PET/CT in the Early Prediction of Cachexia in Lung Cancer Patients
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2023
Completion date
March 1, 2025
Enrollment
150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia, lung neoplasm